Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial.
Franco-Moreno A, Acedo-Gutiérrez MS, Martín NL, Hernández-Blanco C, Rodríguez-Olleros C, Ibáñez-Estéllez F, Suárez-Simón A, Balado-Rico M, Romero-Paternina AR, Alonso-Menchén D, Escolano-Fernández B, Piniella-Ruiz E, Alonso-Monge E, Notario-Leo H, Bibiano-Guillén C, Peña-Lillo G, Antiqueira-Pérez A, Romero-Pareja R, Cabello-Clotet N, Estrada-Pérez V, Troya-García J, de Carranza-López M, Escobar-Rodríguez I, Vallejo-Maroto N, Torres-Macho J.
Franco-Moreno A, et al. Among authors: alonso menchen d.
Trials. 2022 Sep 15;23(1):784. doi: 10.1186/s13063-022-06722-x.
Trials. 2022.
PMID: 36109825
Free PMC article.